Friday, July 10, 2026

pharma · Duchenne muscular dystrophy (DMD) · JAK2V617F-positive high-risk Polycythemia Vera

ITALFARMACO S.P.A

News and analysis for ITALFARMACO S.P.A on NovaPharmaNews — regulatory, clinical, and market coverage.

Cinisello Balsamo, IT HQ
1938 Founded
629 Employees
EMA registrant Type
Company details
Status
Public
HQ
Cinisello Balsamo, IT
Founded
1938
Employees
629
Programs
7
Drugs
17
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning ITALFARMACO S.P.A — regulatory, clinical, and market coverage.

News and analysis for ITALFARMACO S.P.A on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning ITALFARMACO S.P.A yet.

Back to company overview →